Align Technology | ALGN - Ebitda


Align Technology reported $232.86M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
3M USD 2.22B 566M Sep/2026
Align Technology USD 232.86M 3.72M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bruker USD 143.2M 33.2M Jun/2026
Cardinal Health USD 955M 135M Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
CVS Health USD 4.9B 951M Sep/2026
Danaher USD 2.1B 257M Sep/2026
Dentsply International USD 146M 44M Sep/2026
Dexcom USD 435.2M 46.5M Sep/2026
Henry Schein USD 321M 33M Sep/2026
Idexx Laboratories USD 447.35M 21.11M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
McKesson USD 1.97B 262M Sep/2026
Mettler Toledo International USD 366.1M 43.45M Sep/2026
Revvity USD 227.55M 629K Sep/2026
Solventum Corp USD 523M 147M Sep/2026
Stryker USD 1.83B 102M Sep/2026
Teleflex USD 122.91M 47.28M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Veeva Systems USD 422.69M 18.73M Jun/2026
Waters USD 554M 158M Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026
Zoetis USD 1.07B 21M Sep/2026